UBS cuts The RealReal, Inc. target price to $14 from $16
REAL•UBS cut its target price for The RealReal, Inc. to $14 from $16.
Related News
AbbVie’s lutikizumab meets primary endpoint in Phase 3 hidradenitis suppurativa trial
ABBV•
Genasys gets $5 million U.S. Army order for mobile emergency warning systems
GNSS•
IBM falls as analysts question staying power of software rebound
IBM•
U.S. stocks on the move: Quest Diagnostics, Tractor Supply, Dutch Bros
DGX•
UBS raises Tesla target price to $425 from $391
TSLA•